DynoChem Extends Software Agreement with Bristol-Myers Squibb
The agreement will allow Bristol-Myers Squibb to expand deployment of DynoChem process modeling software throughout its Research and Development group and for scale-up into manufacturing.
Bristol-Myers Squibb noted that in meeting the challenges inherent in the scale-up of synthetic pharmaceutical processes, operation modeling allows the company to make efficient use of knowledge and resources to rapidly answer critical questions. In addition, the incorporation of modeling technologies such as DynoChem across Bristol-Myers Squibb's process development enterprise helps achieve the company's development goals faster.
PFD Managing Director Dr. Joe Hannon said, "We are pleased to have the opportunity to expand our relationship with BMS and continue our commitment to their pharmaceutical product development effort. We believe this agreement further validates DynoChem's success in achieving our customers' goals of accelerating process development and lowering drug development costs."
DynoChem(R) is productivity software for scientists and engineers working in chemical process development. DynoChem provides enterprise-wide tools for optimizing unit operations and scale-up through predictive modeling.
About DynoChem Inc.
DynoChem, Inc. is the North American distributor of DynoChem(R), headquartered in Wilmington, DE and is a subsidiary of Performance Fluid Dynamics (PFD) Limited, a Dublin-based company that was named a Deloitte European Technology "Fast 500" winner in 2005. Customers include 11 of the top 12 pharmaceutical companies and major agrochemical and speciality chemical producers.
For further information, please visit www.scale-up.com
Posted: July 2007